Literature DB >> 24306066

[The chemotherapy before or after radiation therapy does not influence survival of children with high-risk medulloblastomas: results of the multicenter and randomized study of the Pediatric Oncology Group (POG 9031)].

R-D Kortmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24306066     DOI： 10.1007/s00066-013-0491-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  11 in total

1.  Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.

Authors:  J P Krischer; A H Ragab; L Kun; T H Kim; J P Laurent; J M Boyett; C J Cornell; M Link; A R Luthy; B Camitta
Journal:  J Neurosurg       Date:  1991-06       Impact factor: 5.115

2.  Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.

Authors:  Roger E Taylor; Clifford C Bailey; Kathryn J Robinson; Claire L Weston; David A Walker; David Ellison; James Ironside; Barry L Pizer; Linda S Lashford
Journal:  Eur J Cancer       Date:  2005-01-18       Impact factor: 9.162

3.  Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Authors:  Susan N Chi; Sharon L Gardner; Adam S Levy; Edmond A Knopp; Douglas C Miller; Jeffrey H Wisoff; Howard L Weiner; Jonathan L Finlay
Journal:  J Clin Oncol       Date:  2004-12-15       Impact factor: 44.544

4.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

5.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

6.  High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).

Authors:  Nancy J Tarbell; Henry Friedman; William R Polkinghorn; Torunn Yock; Tianni Zhou; Zhengjia Chen; Peter Burger; Patrick Barnes; Larry Kun
Journal:  J Clin Oncol       Date:  2013-07-15       Impact factor: 44.544

7.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

8.  Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.

Authors:  Lorenza Gandola; Maura Massimino; Graziella Cefalo; Carlo Solero; Filippo Spreafico; Emilia Pecori; Daria Riva; Paola Collini; Emanuele Pignoli; Felice Giangaspero; Roberto Luksch; Serena Berretta; Geraldina Poggi; Veronica Biassoni; Andrea Ferrari; Bianca Pollo; Claudio Favre; Iacopo Sardi; Monica Terenziani; Franca Fossati-Bellani
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

9.  Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.

Authors:  A D Mosijczuk; M A Nigro; P R Thomas; P C Burger; J P Krischer; R A Morantz; B Kurdunowicz; A F Mulne; R B Towbin; A I Freeman
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

10.  Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

Authors:  R J Packer; L N Sutton; R Elterman; B Lange; J Goldwein; H S Nicholson; L Mulne; J Boyett; G D'Angio; K Wechsler-Jentzsch
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115
View more
  3 in total

1.  Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.

Authors:  Sergiu Scobioala; Ross Parfitt; Peter Matulat; Christopher Kittel; Fatemeh Ebrahimi; Heidi Wolters; Antoinette Am Zehnhoff-Dinnesen; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2017-09-08       Impact factor: 3.621

2.  Early detection of recurrent medulloblastoma: the critical role of diffusion-weighted imaging.

Authors:  Mariam S Aboian; Cassie N Kline; Yi Li; David A Solomon; Erin Felton; Anu Banerjee; Steve E Braunstein; Sabine Mueller; William P Dillon; Soonmee Cha
Journal:  Neurooncol Pract       Date:  2018-02-17

3.  Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis.

Authors:  Anil Öztunali; Khaled Elsayad; Sergiu Scobioala; Mohammed Channaoui; Uwe Haverkamp; Oliver Grauer; Ronald Sträter; Angela Brentrup; Walter Stummer; Kornelius Kerl; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.